XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Additional paid in capital
Accumulated deficit
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2023   336.7      
Beginning balance at Dec. 31, 2023 $ (165.8) $ 0.0 $ 2,598.0 $ (2,742.3) $ (21.5)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   3.4      
Shares withheld related to net share settlement of restricted stock units and awards (in shares)   (1.3)      
Shares withheld related to net share settlement of restricted stock units and awards (41.3)   (12.5) (28.8)  
Repurchases of common stock (in shares)   (11.1)      
Repurchases of common stock (281.6)   (108.8) (172.8)  
Exercise of stock options and awards 0.1   0.1    
Stock-based compensation 78.0   78.0    
Other comprehensive income 1.1       1.1
Net income 132.3     132.3  
Ending balance (in shares) at Mar. 31, 2024   327.7      
Ending balance at Mar. 31, 2024 (277.2) $ 0.0 2,554.8 (2,811.6) (20.4)
Beginning balance (in shares) at Dec. 31, 2024   295.9      
Beginning balance at Dec. 31, 2024 $ (752.4) $ 0.0 2,404.2 (3,146.5) (10.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Release of restricted stock units and awards (in shares)   2.8      
Shares withheld related to net share settlement of restricted stock units and awards (in shares) (1.2) (1.2)      
Shares withheld related to net share settlement of restricted stock units and awards $ (39.8)   (12.9) (26.9)  
Repurchases of common stock (in shares)   (18.1)      
Repurchases of common stock (504.0)   (191.4) (312.6)  
Stock-based compensation 67.1   67.1    
Other comprehensive income 3.1       3.1
Net income 150.3     150.3  
Ending balance (in shares) at Mar. 31, 2025   279.4      
Ending balance at Mar. 31, 2025 $ (1,075.7) $ 0.0 $ 2,267.0 $ (3,335.7) $ (7.0)